Jinru Wei

Peroxisome proliferator-activated receptors and inflammation

Natural product agonists of peroxisome proliferator-activated receptor gamma (PPARγ): a review

Inflammation and tumor progression: signaling pathways and targeted intervention

Immune regulatory cells and IL17-producing lymphocytes in patients with benign and malignant salivary gland tumors

Clinical Guidelines on the Identification, Evaluation, and Treatment of Overweight and Obesity in Adults--The Evidence Report. National Institutes of Health.

Peroxisome Proliferator-Activated Receptor Targets for the Treatment of Metabolic Diseases

Peroxisome proliferator–activated receptor-γ agonist rosiglitazone reduces clinical inflammatory responses in type 2 diabetes with coronary artery disease after coronary angioplasty

Combination of peroxisome proliferator-activated receptor α/γ agonists may benefit type 2 diabetes patients with coronary artery disease through inhibition of inflammatory cytokine secretion

The Treg/Th17 Paradigm in Lung Cancer